Literature DB >> 18755480

Novel experimental model of pressure overload hypertrophy in rats.

Ezequiel J Molina1, Dipin Gupta, Jon Palma, Denise Torres, John P Gaughan, Steven Houser, Mahender Macha.   

Abstract

BACKGROUND: We studied a novel animal model of pressure overload hypertrophy in transition to heart failure following ascending aortic constriction. We sought to assess chronologic changes in hemodynamic parameters, echocardiographic signs of left ventricular (LV) remodeling, exercise tolerance, and profiles of systemic and local inflammation.
MATERIALS AND METHODS: A cohort of Sprague Dawley rats underwent aortic constriction proximal to the innominate artery and were followed by echocardiography. A group of animals were euthanized 20 wk after aortic constriction, before any detectable decline in fractional shortening (normal fractional shortening (FS) or control group; n = 6). When additional animals reached an absolute 25% decline in fractional shortening, they were randomized to be euthanized on d 0 (25% downward arrow FS group; n = 5), or d 21 (>25% downward arrow FS group; n = 6). Hemodynamic and echocardiographic assessment, swim testing to exhaustion, and measurement of systemic and local inflammatory markers was performed at each time interval.
RESULTS: An absolute decline of 25% in FS after aortic constriction was observed between 24 and 28 wk for most animals. The transition from compensated to decompensated hypertrophy was associated with markedly decreased dP/dt(max) and dP/dt(min), increased LV end-systolic diameter and LV end-diastolic diameter, stabilization of LV free wall diameter, decreased exercise performance and up-regulation in expression of interleukin-1, interleukin-6, tumor necrosis factor-alpha, and atrial natriuretic peptide. All animals developed heart failure.
CONCLUSIONS: This study demonstrates that proximal aortic constriction in young rats represents an excellent experimental model of pressure overload hypertrophy that may be useful for testing the efficacy of novel therapies for the treatment of heart failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18755480     DOI: 10.1016/j.jss.2008.03.043

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

Review 1.  Rodent models of heart failure: an updated review.

Authors:  A C Gomes; I Falcão-Pires; A L Pires; C Brás-Silva; A F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

Review 2.  Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series).

Authors:  Sowndramalingam Sankaralingam; Gary D Lopaschuk
Journal:  Pulm Circ       Date:  2015-03       Impact factor: 3.017

3.  Alterations in cardiac structure and function in a modified rat model of myocardial hypertrophy.

Authors:  Wen-Jun Dai; Qi Dong; Min-Sheng Chen; Lu-Ning Zhao; Ai-Lan Chen; Zhen-Ci Li; Shi-Ming Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

4.  A new model of congestive heart failure in rats.

Authors:  Jiqiu Chen; Elie R Chemaly; Li Fan Liang; Thomas J LaRocca; Elisa Yaniz-Galende; Roger J Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-17       Impact factor: 4.733

5.  Changes in cardiac structure and function in a modified rat model of myocardial hypertrophy.

Authors:  Wenjun Dai; Qi Dong; Minsheng Chen; Luning Zhao; Ailan Chen; Zhenci Li; Shiming Liu
Journal:  Cardiovasc J Afr       Date:  2016 May/Jun       Impact factor: 1.167

Review 6.  Morphological and Functional Characteristics of Animal Models of Myocardial Fibrosis Induced by Pressure Overload.

Authors:  Yuejia Ding; Yuan Wang; Qiujin Jia; Xiaoling Wang; Yanmin Lu; Ao Zhang; Shichao Lv; Junping Zhang
Journal:  Int J Hypertens       Date:  2020-01-31       Impact factor: 2.420

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.